| 000 | 01486 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515035853.0 | ||
| 264 | 0 | _c20070222 | |
| 008 | 200702s 0 0 eng d | ||
| 022 | _a0014-2972 | ||
| 024 | 7 |
_a10.1111/j.1365-2362.2006.01681.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBeghetti, M | |
| 245 | 0 | 0 |
_aCurrent treatment options in children with pulmonary arterial hypertension and experiences with oral bosentan. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical investigation _cSep 2006 |
||
| 300 |
_a16-24 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBosentan |
| 650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 |
_aEpoprostenol _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypertension, Pulmonary _xdrug therapy |
| 650 | 0 | 4 |
_aIloprost _xadministration & dosage |
| 650 | 0 | 4 |
_aNitric Oxide _xadministration & dosage |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aReceptors, Endothelin _xdrug effects |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 |
_aVasodilator Agents _xtherapeutic use |
| 773 | 0 |
_tEuropean journal of clinical investigation _gvol. 36 Suppl 3 _gp. 16-24 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1365-2362.2006.01681.x _zAvailable from publisher's website |
| 999 |
_c16505541 _d16505541 |
||